The Eversense CGM is a continuous glucose monitor with implantable sensor for measuring glucose levels continually for up to 90 days in adults aged 18 years and older with either type 1 or type 2 diabetes. The Eversense CGM System consists of 3 components: an implantable cylindrical glucose sensor, a wearable smart transmitter, and a handheld device running a mobile medical application. The transmitter is worn over the implanted sensor for continuous readout of glucose data, but can be removed and replaced without the need for sensor replacement. The Eversense CGM system works in tandem with a mobile application that allows for the real-time display of interstitial glucose readings. The transmitter stores glucose data and provides the patient with on-body vibrations for notification of hypoglycemia and hyperglycemia.

If you have a Hayes login, click here to view the full report on the Knowledge Center.